Tae‐Sung Koo

889 total citations
60 papers, 702 citations indexed

About

Tae‐Sung Koo is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Tae‐Sung Koo has authored 60 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Oncology and 13 papers in Pharmacology. Recurrent topics in Tae‐Sung Koo's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Tae‐Sung Koo is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Tae‐Sung Koo collaborates with scholars based in South Korea, Ethiopia and United States. Tae‐Sung Koo's co-authors include Kyeong‐Ryoon Lee, Yoon‐Jee Chae, Soo‐Jin Kim, Jong‐Hwa Lee, Han‐Joo Maeng, Thi‐Thao‐Linh Nguyen, Kyoung‐Won Seo, Nam Sook Kang, Young Ho Cho and Tae‐Heon Kim and has published in prestigious journals such as Cancer Research, Chemical Communications and International Journal of Molecular Sciences.

In The Last Decade

Tae‐Sung Koo

57 papers receiving 681 citations

Peers

Tae‐Sung Koo

ONCOL

PHARM

Guofei Li China

Ana Fernández-Carballido Spain

Ying Feng China

Neil Mathias United States

Kazuki Matsui Japan

Stephen T. Buckley Denmark

Veli‐Pekka Ranta Finland

Norio Yasui Japan

F. Lapicque France

Guofei Li China

Tae‐Sung Koo

186 ×0.8

84 ×0.8

ONCOL

95 ×1.0

73 ×0.9

PHARM

43 ×0.5

Citations per year, relative to Tae‐Sung Koo Tae‐Sung Koo (= 1×) peers Guofei Li

Countries citing papers authored by Tae‐Sung Koo

Since Specialization

Citations

This map shows the geographic impact of Tae‐Sung Koo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tae‐Sung Koo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tae‐Sung Koo more than expected).

Fields of papers citing papers by Tae‐Sung Koo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tae‐Sung Koo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tae‐Sung Koo. The network helps show where Tae‐Sung Koo may publish in the future.

Co-authorship network of co-authors of Tae‐Sung Koo

This figure shows the co-authorship network connecting the top 25 collaborators of Tae‐Sung Koo. A scholar is included among the top collaborators of Tae‐Sung Koo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tae‐Sung Koo. Tae‐Sung Koo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Choi, Jin‐Young, et al.. (2024). Stability Evaluation and Pharmacokinetic Profiling of Vepdegestrant in Rodents Using Liquid Chromatography–Tandem Mass Spectrometry. Molecules. 29(17). 4048–4048. 2 indexed citations

Kim, Hyunwoo, Kun Woo Kim, Sung Jean Park, et al.. (2023). Novel Strategy To Inhibit Transthyretin Amyloidosis via the Synergetic Effect of Chemoselective Acylation and Noncovalent Inhibitor Release. Journal of Medicinal Chemistry. 66(4). 2893–2903. 2 indexed citations

Jang, Dong-Jin, et al.. (2023). The Development of Super-Saturated Rebamipide Eye Drops for Enhanced Solubility, Stability, Patient Compliance, and Bioavailability. Pharmaceutics. 15(3). 950–950. 3 indexed citations

Lee, Seungbeom, Juhee Lim, Tae‐Sung Koo, et al.. (2021). ERRγ ligand HPB2 upregulates BDNF-TrkB and enhances dopaminergic neuronal phenotype. Pharmacological Research. 165. 105423–105423. 27 indexed citations

Kim, Tae‐Heon, Seungwon Lee, Hyun Jin Park, et al.. (2021). Bioanalysis of niclosamide in plasma using liquid chromatography-tandem mass and application to pharmacokinetics in rats and dogs. Journal of Chromatography B. 1179. 122862–122862. 18 indexed citations

Han, Ah Reum, Eun Hee Jeon, Kun Woo Kim, et al.. (2021). Synthesis and biological evaluation of quinolone derivatives as transthyretin amyloidogenesis inhibitors and fluorescence sensors. Bioorganic & Medicinal Chemistry. 53. 116550–116550. 5 indexed citations

Koo, Tae‐Sung, et al.. (2020). Protective effects of PARP1-inhibitory compound in dry age-related macular degeneration. Biomedicine & Pharmacotherapy. 133. 111041–111041. 9 indexed citations

Lee, Jong‐Hwa, et al.. (2019). Determination of motolimod concentration in rat plasma by liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 179. 112987–112987. 6 indexed citations

Kang, Nam Sook, et al.. (2018). Liquid chromatography–tandem mass spectrometry of recombinant human extracellular superoxide dismutase (rhSOD3) in mouse plasma and its application to pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 164. 590–597. 4 indexed citations

10.

Kim, Jae Yeol, et al.. (2018). Orlistat-loaded solid SNEDDS for the enhanced solubility, dissolution, and in vivo performance. International Journal of Nanomedicine. Volume 13. 7095–7106. 27 indexed citations

11.

Balupuri, Anand, et al.. (2018). Discovery and optimization of ATX inhibitors via modeling, synthesis and biological evaluation. European Journal of Medicinal Chemistry. 148. 397–409. 8 indexed citations

12.

Koo, Tae‐Sung, et al.. (2018). Protective effect of RIPK1-inhibitory compound in in vivo models for retinal degenerative disease. Experimental Eye Research. 180. 8–17. 28 indexed citations

13.

Koo, Tae‐Sung, et al.. (2018). Simultaneous Quantification of Enzalutamide and Its active Metabolite and Characterization of the Kinetics of Active Metabolite in Rats. Yakhak Hoeji. 62(2). 63–70. 1 indexed citations

14.

Song, Kun‐Ho, et al.. (2018). Comparative single-dose pharmacokinetics of sildenafil after oral and rectal administration in healthy beagle dogs. BMC Veterinary Research. 14(1). 291–291. 8 indexed citations

15.

Lee, Jong‐Hwa, et al.. (2017). Development and validation of a liquid chromatography–tandem mass spectrometry method for the assay of tafamidis in rat plasma: Application to a pharmacokinetic study in rats. Journal of Pharmaceutical and Biomedical Analysis. 137. 90–95. 12 indexed citations

16.

Lee, Kyeong‐Ryoon, Sunjoo Ahn, Sungwook Choi, et al.. (2017). Pharmacokinetics of tafamidis, a transthyretin amyloidosis drug, in rats. Xenobiotica. 48(8). 831–838. 2 indexed citations

17.

Hwang, Juen-Haur, et al.. (2017). Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs. Journal of Veterinary Internal Medicine. 31(3). 743–750. 19 indexed citations

18.

Kim, Boyoung, Seul Ki Lee, Sung Jean Park, et al.. (2016). Systemic optimization and structural evaluation of quinoline derivatives as transthyretin amyloidogenesis inhibitors. European Journal of Medicinal Chemistry. 123. 777–787. 13 indexed citations

19.

Jang, Woo Dae, Seung Yeon Park, Young Sik Cho, et al.. (2015). Discovery of Tyk2 inhibitors via the virtual site-directed fragment-based drug design. Bioorganic & Medicinal Chemistry Letters. 25(18). 3947–3952. 12 indexed citations

20.

Ahn, Sung‐Hoon, Han‐Joo Maeng, Tae‐Sung Koo, et al.. (2006). Quantification of clotiazepam in human plasma by gas chromatography–mass spectrometry. Journal of Chromatography B. 834(1-2). 128–133. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact